Drugs / F105
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001105 | ? → Mar 1996 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001105 ↗ |
| Modality | Monoclonal antibody | “F105 human monoclonal antibody” NCT00001105 ↗ |
| Route | Intravenous | “single intravenous (IV) injection of F105 human monoclonal antibody” NCT00001105 ↗ |